INTRODUCTION
============

Restriction--modification (RM) systems, which are abundant among prokaryotic cells ([@B1]) attack invading DNAs to defend against invading genetic elements such as phages. However, many lines of evidence indicate that the RM systems themselves are mobile since they are found in mobile elements such as: plasmids, phages, integrons, transposons and conjugative transposons ([@B2]). The structure of some restriction gene complexes is related to that of transposons, and these may move as a part of composite transposons (3,4,5). In some naturally competent bacteria, restriction gene complexes move without other linked genes, for example by insertion involving a long variable target duplication ([@B6]). A comparison of closely related prokaryotic genomes revealed linkage of restriction gene homologs with various large genome polymorphisms and rearrangements ([@B2],[@B7]). Similar to some pathogenic mobile elements, RM systems sometimes attack their hosts ([@B8]) and, like viral genomes and transposons, may be regarded as selfish mobile elements or opportunistic pathogens.

The extreme sequence diversity seen in the restriction (R) enzymes that form RM systems ([@B9],[@B10]) could be related to their interaction with the host bacteria. RM systems consist of two enzymatic activities, a restriction endonuclease (R) that recognizes a specific DNA sequence and introduces a double-strand break, and a cognate modification enzyme (M) that protects the host genome from self-cleavage by methylating the cognate recognition sites ([@B11]). At least some type II RM systems, in which restriction enzymes cleave at or near a fixed sequence ([@B10]), have been observed to kill cells that have lost their genes in a process called post-segregational killing ([@B7]). Transcriptome analysis further suggests that they trigger a bacterial programmed death pathway that is also activated by bactericidal antibiotics ([@B12]).

Some type II restriction enzymes, called Type IIE, interact with two copies of their recognition sequence but cleave only one ([@B10],[@B13]); while others called Type IIF interact and cleave both the sites coordinately ([@B13]). The crystal structures of some Type IIF enzymes such as NgoMIV ([@B14]), Cfr10I ([@B15]) and Bse634I ([@B16]) show that two subunits form one of the equivalent DNA binding sites, and two such dimers pack back-to-back to constitute an active tetramer. These restriction endonucleases interact with two recognition sites *in cis* by forming a DNA loop ([@B17],[@B18]). Their reaction mechanisms ([@B19],[@B20]) and structures have been elucidated ([@B14; @B15; @B16]), but their biological significance is still not clear.

The restriction enzymes are also structurally diverse ([@B21]). Five restriction enzyme folds have been determined by structural and bioinformatics analyses: the PD-(D/E)XK nuclease fold, the HNH (= ββα-Me) fold, the GIY-YIG fold, the phospholipase D fold that includes R.BfiI, and the half-pipe fold that includes R.PabI. Many restriction enzymes remain unassigned to any of these, and may exhibit new architectures ([@B9]). A novel restriction enzyme structure would enlarge the structural universe of DNA-interacting proteins. We have developed a genome comparison method, based on the mobility of RM genes, to identify restriction enzymes with novel structure ([@B22]). We compared two closely related genomes and found a subgenomic region specific to one of the genomes and encompassing a DNA methyltransferase homolog and an open reading frame (ORF) lacking similarity to any structurally characterized protein ([@B23]). Restriction enzyme activity was observed for this ORF in an enzyme assay after *in vitro* protein expression using wheat germ extract ([@B22]), and subsequently the encoded enzyme, named R.PabI, was found to have a novel fold ([@B24]).

We have extended the genome comparison and genome context analysis to available prokaryotic genomes to find a restriction enzyme of novel structure. Here, we present a newly characterized restriction endonuclease, R.PluTI, that may well represent a novel endonuclease fold architecture. This enzyme forms an RM-system with its cognate methyltransferase, M.PluTI. The PluTI RM-system along with two other hypothetical genes is present on a putative mobile element.

MATERIALS AND METHODS
=====================

Materials
---------

*Escherichia coli* K12 strain JM109 {*recA1*, *endA1*, *gyrA96*, *thi*, *hsdR17*, , *e*14^−^(*mcrA*^−^), *supE44*, *relA*, Δ(*lac-proAB*)/F*\'* \[*traD*36, *proAB*^+^, *lacI*^q^, *lacZ*Δ*M15*\]} was a gift from Dr Akio Nomoto (University of Tokyo) ([@B25]). *Escherichia coli* strain ER2566 (*fhuA2 lacZ*::*T7 gene1* \[*lon*\] *ompT gal sulA11 R(mcr-73::mini*Tn*10*--Tet^S^*)2* \[*dcm*\] *R(zgb-210::*Tn*10--*Tet^S^*) endA1* Δ*(msrC-mrr)114::*IS*10* was from New England Biolabs, Inc, USA. *Escherichia coli* strain BL21-DE3 F^--^ *dcm ompT hsd*S gal λ(DE3) was from Novagen.

*Photorhabdus luminescens* subsp. laumondii TTO1 genomic DNA ([@B26]) was provided by Dr Alain Givaudan (Université Montpellier). The vector plasmid pTXB1, LITMUS38i, pBR322 and pUC19 were from New England Biolabs, Inc.; *φ*X174 DNA (replicative form) and λ-phage DNA were from Takara Bio Inc; pET26b and pET28a were from Novagen. The plasmid pBAD33 ([@B27]) was provided by Dr Miki Watanabe (University of Tokyo) and pEU3b ([@B28]) by Dr Yaeta Endo (Ehime University). Plasmids pFK1 and pFK2 were constructed from LITMUS38i (see [Supplementary Methods](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1) for details).

Bioinformatics
--------------

Genome sequences were obtained from the National Center for Biotechnology Information (NCBI) Genome database (<http://www.ncbi.nlm.nih.gov/Genomes/>). Homologs of hypothetical and unknown protein genes that flanked a DNA methyltransferase gene homolog, as judged by genome comparison and genome context analysis to be present on the same variable unit, were searched using PSI-BLAST ([@B29]) and HHSEARCH ([@B30]). Protein secondary and tertiary structure predictions used the GeneSilico metaserver ([@B31]). Homology searches were done in October 2009. The details of systematic genome comparison will be presented elsewhere (M.K., K.K., J.M.B. and I.K., unpublished data).

Screening, expression and purification of R.PluTI
-------------------------------------------------

The *pluTIR* ORF was inserted into plasmid pEU3b ([@B28]), for *in vitro* screening and expression, and the protein was expressed using a wheat-germ expression kit WEPRO® (CellFree Sciences Co, Ltd, Japan). Restriction activity was monitored as the ability of a crude R.PluTI extract to digest *φ*X174 DNA (replicative form). PhoI ([@B22]) was used as control for restriction activity. For *in vivo* expression, *pluTIR* gene was inserted into the T7-promoter based pTXB1 expression vector. R.PluTI was purified by affinity and ion-exchange chromatography (see [Supplementary Methods](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1) for details).

Characterization of R.PluTI
---------------------------

The recognition sequence was determined as described earlier ([@B22]) and cleavage position was determined by the primer extension method ([@B32]) (see [Supplementary Methods](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1) for details). Optimal reaction conditions were determined with different buffers, salt concentrations and reaction temperatures as described in [Supplementary Methods](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1).

Cleavage kinetics
-----------------

Substrate cleavage kinetics were monitored as time-dependent changes in the concentrations of substrate (supercoiled plasmid) and products: open circular (OC), full-length linear (FLL) and linear fragments (L1 and L2). The *K*~m~ and *V*~max~ were determined by non-linear fitting of the initial reaction velocity for the linear and supercoiled substrates with one or two sites at different substrate concentrations (see [Supplementary Methods](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1) for details).

*In vivo* activity of M.PluTI and toxicity of R.PluTI
-----------------------------------------------------

*In vivo* activity of M.PluTI was assessed as ability to protect a plasmid from *in vitro* cleavage with R.PluTI. *In vivo* toxicity of R.PluTI was demonstrated as loss of cell viability in cells induced to produce R.PluTI in the absence of active methylation. (see [Supplementary Methods](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1) for details).

RESULTS
=======

Genome comparison predicts a mobile unit with a restriction enzyme from a novel sequence family
-----------------------------------------------------------------------------------------------

A bioinformatic survey of systematic genome comparisons discovered, in the genome of a *Photorhabdus luminescence* strain, a subgenomic, potentially mobile unit containing a DNA methyltransferase homolog (plu0600) and three other genes, lying between plu0594 (4-hydroxy-3-methylbut-2-enyl diphosphate reductase) and plu0602 (dihydrodipicolinate reductase) ([Figure 1](#F1){ref-type="fig"}). This rod-shaped bacterium (classification: *Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobactereriaceae; Photorhabdus; Photorhabdus luminescens* subsp*. laumondii* TTO1) lives symbiotically in the gut of nematodes that attack insect larvae and eventually kill their host using various toxins ([@B26],[@B33]). Figure 1.Genome organization of the PluTI RM complex. *pluTIR* and *pluTIM* genes are shown in solid boxes. The flanking 16-bp direct repeats are shown below. IS*Plu6* indicates nucleotide sequence similarity to the 3\'-end of IS*Plu6* of IS*982* family, while IS indicates homology to the 3\'- and 5\'-ends of IS copies from another subfamily of the IS*982* family.

The alignment of the *P. luminescence* genome with others revealed that the DNA methyltransferase-containing unit is substituted by diverse sequences. The observed 46 substitution cases were classified into six groups based on mutual homology ([Table 1](#T1){ref-type="table"}). Group A contained eight cases and had no annotated genes in the substitution region. In Group B, the unit was substituted with a hypothetical protein gene. Group C had seven cases all with an insertion of IS*1541*. Group D contained substitutions of the ribonucleoside hydrolase RihC gene only (Subgroup D-1) or RihC with other genes (Subgroup D-2). Group E contained a substitution of the LysR family transcriptional regulator gene only (Subgroup E1) or LysR with other genes (Subgroup E2). Finally, Group F comprised one case containing several genes, including the AraC family transcriptional regulator gene. Table 1.Gene clusters substituting the PluTI unitGroupMembers foundRepresentativeAccession numberplu594 homologplu602 homologInsertion length (average of members)Annotation of some of genes presentA8*Escherichia coli* ATCC 8739NC_010468.1EcolC_3626EcolC_36241502no geneB3*Yersinia pseudotuberculosis* IP 31758NC_009708.1YpsIP31758_3457YpsIP31758_34551621hypothetical proteinC7*Yersinia pseudotuberculosis* IP 32953NC_006155.1YPTB0620YPTB06222081transposase of IS1541D-121*Escherichia coli* SMS-3--5NC_010498.1EcSMS35_0027EcSMS35_00292610ribonucleoside hydrolase RihCD-24*Salmonella enterica* subsp. *enterica*serovar Paratyphi B str. SPB7NC_010102.1SPAB_00059SPAB_0007616 343ribonucleoside hydrolase RihC, oxaloacetate decarboxylaseE-11*Enterobacter* sp. 638NC_009436.1Ent638_0587Ent638_05902735LysR family transcriptional regulatorE--21*Serratia proteamaculans* 568NC_009832.1Spro_0701Spro_071213 291LysR family transcriptional regulator,dihydrodipicolinate synthetase,dihydroxy-acid dehydrataseF1Sequence 16855 from patent US 7319142EA414747.1N/A^a^N/A^a^12 316AraC-family transcriptional regulator^b^, major facilitator superfamily MFS_1^b^[^1][^2]

In Subgroup E-2, the substituted region contained dihydrodipicolinate synthetase gene, whose product is known to act in the same pathway as dihydrodipicolinate reductase (product of the plu0602 gene) (<http://www.genome.jp/kegg/>) ([@B34]), which lies next to the putative mobile unit ([Figure 1](#F1){ref-type="fig"}). Thus, we suggest that Subgroup E-2 may represent the ancient form of this locus, in which gene loss occurred resulting in an empty site as in Group A. This site experienced the insertion of various genes such as IS, the putative mobile unit identified here, and other genes.

Direct repeats flanking the PluTI unit
--------------------------------------

A BLASTN search for internal sequence similarity around the DNA methyltransferase homolog-containing unit (discussed above) showed 16-bp direct repeats flanking the unit ([Figure 1](#F1){ref-type="fig"}). The repeats showed perfect (16/16) sequence matches and were not found elsewhere in the genome, suggesting a possible horizontal transfer of this unit, followed by its insertion into the genome by the site-specific recombination, similar to DNA phage genomes.

However, upon closer examination, the direct repeats appeared to be derived from IS elements ([Supplementary Materials](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1)). The left repeat ([Figure 1](#F1){ref-type="fig"}) is located in a region homologous to IS*Plu6* ([@B26]) (IS Finder, <http://www-is.biotoul.fr/>), an IS*982* family member. The right repeat is located in a region homologous to another subfamily of IS*982* family ([@B35]). These observations raise the other possibility of site-specific integration that the unit entered in the genome through some action of these terminal IS elements such as aberrant transposition and non-autonomous transposition.

Biochemical and biological experiments (described later) demonstrated that the plu0599 (= *pluTIR*) gene, which has no sequence similarity to any gene for any functionally or structurally characterized protein, encodes a restriction enzyme, designated R.PluTI, and that the plu0600 gene (= *pluTIM*) encodes a modification methyltransferase, designated M.PluTI, which together constitute PluTI RM system (discussed below). The modification enzyme has also been annotated in REBASE.

Restriction enzyme activity detected by *in vitro* expression
-------------------------------------------------------------

The candidate ORF *pluTIR* (plu0599) was amplified from *P. luminescens* genomic DNA by PCR and placed in a vector for *in vitro* expression, pEU3b ([@B28]). DNA purified from transformed *E. coli* was transcribed *in vitro* with SP6 RNA polymerase, and proteins synthesized using wheat-germ extract. The product showed clear *in vitro* restriction endonuclease activity on a substrate DNA (*φ*X174 DNA, replicative form) ([Figure 2](#F2){ref-type="fig"}). Figure 2.Detection of restriction activity of cell-free translation products. mRNA synthesized *in vitro* was incubated with a wheat-germ-based *in vitro* translation mixture. The extract was then incubated with *φ*X174 DNA (replicative form) for 1 h at 37°C (65°C for PhoI), and the digest resolved on 1% agarose gel and visualized with ethidium bromide staining. Marker, perfect DNA marker (Novagen); Extract, wheat-germ extract; Substrate, *φ*X174 DNA (replicative form); DHFR, dihydrofolate reductase (negative control for restriction activity); PhoI, restriction enzyme PhoI (positive control for restriction activity); PluTI, wild-type R.PluTI; PluTI^H^, 6His-tagged R.PluTI; PluTI^C^, cloned R.PluTI (with two extra amino acid residues at the N terminus) purified following *in vivo* expression in *E. coli*. SC, supercoiled; OC, open circle; Lin, linear.

Characterization of purified R.PluTI
------------------------------------

The purified and refolded recombinant R.PluTI (see [Supplementary Materials](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1)) was found to be active at pH 7 and 20--37°C temperature, and required Mg^2+^ ion for DNA cleavage. The monomeric molecular mass of tagged R.PluTI determined by SDS--PAGE ([Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1)), and deduced from the amino acid sequence was 38.6 and 39.1 kDa, respectively. The native molecular mass was 140 (±15) kDa as determined by gel filtration ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1)), suggesting that R.PluTI forms a homotetramer (α~4~) similar to other Type IIF enzymes (see below). R.PluTI is thermolabile and lost 100% activity after 30 min at 65°C. One unit of R.PluTI was defined as the amount of enzyme required for complete digestion of 1 µg of *φ*X174 DNA (replicative form) in 1 h at 37°C in a 50 µl reaction and specific activity of purified enzyme was 8000 U/mg.

The recognition sequence of R.PluTI was predicted to be 5′-GGCGCC-3′ by REBpredictor ([@B36]) using the cleavage pattern of pUC19 and *φ*X174 DNA (replicative form) ([Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1)), similar to EheI, BbeI, NarI, DinI, EgeI, KasI, SfoI, SspDI and Mly113I. The cleavage position was determined to be 5′-GGCGC↓C-3′ by comparison of a dideoxy sequencing ladder with fragments generated by R.PluTI cleavage ([Supplementary Figure S4](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1)).

Kinetic analysis
----------------

Efficient cleavage of a two-site plasmid in contrast to a one-site plasmid ([Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1)) suggested the possibility that R.PluTI requires two copies of its recognition sequence for efficient cleavage. Many restriction enzymes such as Type I, IIB, IIE, IIF, most IIS, III and IV enzymes require two-sites for optimal activity ([@B10]). The mode of action can be deduced from reactions that occur in the presence of two supercoiled substrate DNAs: one with a single copy of the recognition sequence (one-site) and the other with two copies (two-site) ([@B19],[@B37]). If an enzyme must bind two sites before cleavage, the cleavage rate *in cis* reaction for two-site substrates will be much higher than *in trans* reaction for one-site substrates.

This mechanism is distinguished by steady-state cleavage reactions when enzyme concentration is considerably lower than the substrate. Based on the one-site plasmid, LITMUS38i, we constructed a two-site plasmid, pFK1 with two R.PluTI sites placed 853 bp away from each other, with identical flanking sequences ([Supplementary Figure S6](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1)). R.PluTI consumed initial 10% substrate at a rate of 0.011 nM/min for the one-site substrate, and 0.28 nM/min for the two-site substrate ([Figure 3](#F3){ref-type="fig"}). In the reaction on a SC one-site plasmid, OC form that was cut only at one strand was generated, along with a relatively small fraction of FLL form cut on both strands ([Figure 3](#F3){ref-type="fig"}a--b). In contrast, products from the two-site plasmid were mainly linear fragments L1 and L2, which were formed by cleavage of both strands at both sites ([Figure 3](#F3){ref-type="fig"}c--d). Less amounts of the FLL and OC forms were obtained, indicating concerted cleavage mechanism working at both sites. These kinetics were very similar to those of NgoMIV, a Type IIF enzyme ([@B19]). Figure 3.R.PluTI reactions on one- and two-site plasmids. Reaction contained 0.5 nM of purified R.PluTI and 4 nM of supercoiled (SC) DNA in NEB1\* buffer (10 mM Tris--propane buffer, pH 7.0 supplemented with 10 mM MgCl~2~, 1 mM dithiothreitol and 100 µg/ml BSA) at 37°C. DNA was (**a** and **b**), LITMUS 38i, with one R.PluTI site; (**c** and **d**), pFK1 with two R.PluTI sites. (**a** and **c**) Agarose gel electrogram of DNA taken from the reaction at the indicated time: electrophoretic mobilities of open-circle (OC), full-length linear (FLL), supercoiled (SC) and reference DNAs (1.3 kb linear fragment) are marked on the right, in (**c**) two linear products (L1 and L2) resulting from cutting at the both sites are also marked. (**b** and **d**) Concentrations of substrate (SC) and products (OC, FLL and average of L1, L2) over 120 min of reaction. Error bars (shown only one side, and in some cases masked by symbols) indicate standard deviation from three or more independent sets of experiments.

If a cleavage reaction requires two sites, the slow cleavage reaction against the one-site supercoiled plasmid may be enhanced by addition of an oligoduplex carrying the recognition sequence ([@B38]). Addition of such a duplex carrying the R.PluTI site initially enhanced cleavage of an SC plasmid ([Figure 4](#F4){ref-type="fig"}) as reported for another Type IIF enzyme ([@B39]), but inhibited at higher concentrations, because of engagement of the enzyme molecule between two molecules of oligoduplex, rather than an oligoduplex and a plasmid ([@B38]). Figure 4.Effect of oligoduplexes on one-site plasmid cleavage. (**a**) Varying concentrations of oligoduplexes with fixed plasmid concentration. Reactions at 37°C contained 0.5 nM of purified R.PluTI and 4 nM of supercoiled (SC) LITMUS38i DNA in NEB1\* buffer (10 mM Tris--propane buffer, pH 7.0 supplemented with 10 mM MgCl~2~, 1 mM dithiothreitol, and 100 µg/ml BSA) and oligoduplexes with (solid squares) or without (open squares) the recognition sequence at concentrations indicated on the vertical axis. Reactions were stopped after 30 min; and samples were analyzed for the residual concentration of supercoiled LITMUS38i. (**b** and **c**) Varying concentrations of plasmid with a fixed concentration of oligoduplexes. Reaction, contained 0.5 nM of purified R.PluTI and varying concentration of supercoiled (SC) DNA (indicated on vertical axes) in NEB1\* buffer (described above) and 100 nM oligoduplex. Following forms of the DNA were monitored over 120 min: SC substrate, OC DNA, FLL DNA. Oligoduplex without (b) and with (c) the recognition sequence were used. In all the three panels, error bars (masked by symbols in some cases) indicate standard deviation from three or more independent sets of experiments.

The *K*~m~ and *V*~max~ were determined for one- or two-site linear and supercoiled DNA substrates ([Table 2](#T2){ref-type="table"}, [Supplementary Figure S5](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1)); and the enzyme was found to obey Michaelis--Menten kinetics ([Supplementary Figure S5](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1)) similar to other restriction enzymes ([@B40],[@B41]). The two-site SC substrate showed a 27-fold higher *V*~max~ than the one-site SC substrate, while this difference was insignificant between the one- and two-site linear substrates. The *V*~max~ values for the one-site linear and the two-site linear substrate were between these values: \[two-site SC\] \> \[two-site linear\] = \[one-site linear\] \> \> \[one-site SC\]. Superhelicity appeared to facilitate the reaction with two-site substrates but suppress the reaction with one-site substrates, which could be attributed to steric hindrance, as the supercoiled nature of plasmid DNA reduces the efficiency of *trans* interactions ([@B38]). Table 2.*V*~max~ and *K*~m~ with various substratesSubstrate*V*~max~ (nM/min)*K*~m~ (nM)One-site supercoiled0.233Two-site supercoiled5.457One-site linear1.520Two-site linear1.412[^3]

M.PluTI prevents the cleavage of DNA by R.PluTI
-----------------------------------------------

The activity of the plu0600 product M.PluTI was examined *in vivo*. Plasmid pBAD33-*pluTIM* carries two R.PluTI sites in 20 bp proximity so reactions *in cis* are not feasible. Indeed, even unmethylated plasmid DNA was not efficiently cleaved by R.PluTI while it was cleaved by EheI (data not shown). Therefore, we constructed pET26b-*pluTIM* having four R.PluTI sites, which was cleaved with R.PluTI or EheI *in vitro* in uninduced cell ([Supplementary Figure 7a](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1)), while in IPTG-induced cells, it was efficiently protected from *in vitro* cleavage by R.PluTI or EheI.

*In vivo* toxicity of R.PluTI to host cells was suppressed by induction of M.PluTI ([Supplementary Figure 7b](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1)). Taken together with the informatics data, these results support that M.PluTI is a modification enzyme that forms an RM system with R.PluTI.

R.PluTI sequence analysis and structure prediction
--------------------------------------------------

A PSI-BLAST search against the NCBI non-redundant database revealed 12 homologs of R.PluTI ([Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1)). Of these, nine were linked to an M.PluTI homolog, with the same relative order and orientation (M precedes R in the same orientation, [Figure 1](#F1){ref-type="fig"}). The other three appeared truncated compared to the other homologs. The genes flanking *pluTIR* and *pluTIM* homologs were not homologous to each other, supporting the frequent movement of the RM system as a unit.

Analysis of residue conservation patterns in the R.PluTI family ([Figure 5](#F5){ref-type="fig"}), and fold-recognition searches of the database of known structures revealed no overall similarity of these proteins to any of the known restriction enzyme superfamilies or folds, including PD-(D/E)XK, GIY-YIG, HNH, PLD-nuc and Half-pipe (PabI) ([@B9],[@B21],[@B24],[@B42; @B43; @B44; @B45]). Secondary structure prediction suggested that R.PluTI exhibits α/β structure, with invariant or nearly invariant charged and polar residues concentrated in the middle of the sequence, mostly at the termini of predicted helices and strands, and in loops. This conservation pattern is typical for enzymes, including nucleases. Figure 5.Amino acid sequence alignment of R.PluTI and its PSI-BLAST matches (see [Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1) for detail). BL0974 and E4_15863 have been omitted from the alignment, as they are apparently products of degenerated genes (their sequences exhibit terminal truncations, in BL0974 the missing C-terminal part has been replaced with unrelated low-complexity sequence). A frameshift in Blon_0091 was corrected to restore the conserved C-terminal sequence. The alignment was prepared by PROMALS ([@B56]) and manually edited. The secondary structure prediction was carried out using the GeneSilico metaserver ([@B31]). The highlighted residues show \>90% identity or similarity. E, extended (β); H, helical (α); asterisk, residues predicted to be involved in cleavage activity and/or DNA binding.

Regardless of the actual structure, and apart from the invariant or nearly invariant residues D211, H220 and T222, the residues R82, E149, R168, K184, D203, R208, T223, R232, N280, E283, Y303 and N304 are conserved ([Figure 5](#F5){ref-type="fig"}), and may be involved in R.PluTI DNA-binding and cleavage activity. The residues E311, D313 and D319 are also conserved. Some of these conserved residues might be involved in tetramer formation.

The N-terminal region of the R.PluTI family appears divergent, but 9 out of the 11 members in the [Figure 5](#F5){ref-type="fig"} possess the conserved amino acid sequence EGGRTSRG (amino acid 87--94 in [Figure 5](#F5){ref-type="fig"}), which might be involved in DNA binding, as suggested by protein--DNA binding residue prediction programs ([@B46],[@B47]).

Genomic contexts of the gene pair linked to PluTI RM genes
----------------------------------------------------------

The plu0597 and plu0598 genes, besides the PluTI RM genes, are also within the region flanked by the short direct repeats ([Figure 1](#F1){ref-type="fig"}). The possibility that these two genes play some role in the life cycle of this putative mobile element is suggested by their amino acid sequences and genome contexts. The products of both genes have a P-loop-containing domain that is conserved in nucleoside triphosphate hydrolases (cl09099), according to the Conserved Domain Database (CDD) ([@B48]). Proteins with this motif include DNA-interacting proteins such as helicases and putative endonucleases.

BLASTP and PSI-BLAST analyses showed that plu0597 product has sequence similarity to helicases with *e*-values of 1e-17 and 8e-91, respectively. RPS-BLAST searches against the Conserved Domain Database (*e*-value 8e-21) showed plu0598 was similar to the COG3593, OLD (*o*vercome *l*ysogenization *d*efect) nuclease family. The bacteriophage P2 OLD protein has DNase and RNase activities and consists of an N-terminal ABC-type ATPase domain and a C-terminal TOPRIM domain ([@B49],[@B50]). These domains were also detected at the N- and C-terminus of plu0598, respectively.

We also found several homologs of plu0597 and plu0598 genes (*e*-value: 1e-110 to 2e-93 for plu0597 and 1e-141 to 1e-118 for plu0598) adjacent to each other on putative mobile elements including integrated plasmids, transposon-like structures or composite transposon-like structures, suggesting that these two genes might be involved in genome mobility ([Figure 6](#F6){ref-type="fig"}). A homologous pair ([Figure 6](#F6){ref-type="fig"}a) was found in a region annotated as a plasmid integrated into the 3′-terminus of a tRNA gene resulting in 40-bp long flanking direct repeats. Another homologous pair ([Figure 6](#F6){ref-type="fig"}b) was flanked by 21-bp inverted repeats of 19/21 bp identity next to a transposase homolog. This structure is similar to those of transposons such as Tn*3* in which a transposase and a resolvase catalyze site-specific recombination for cointegrated resolution ([@B51]). In three other cases ([Figure 6](#F6){ref-type="fig"}c--e), the homologous pair is next to an IS*1* copy. The relative position and orientation of the homologous pair and IS*1* are the same in these three clusters, suggesting that they form a mobile unit or a composite transposon. In these three cases ([Figure 6](#F6){ref-type="fig"}c--e), the homologous pair is also adjacent to the VagCD system, a toxin--antitoxin system ([@B52]). In another case ([Figure 6](#F6){ref-type="fig"}f), the homologous pair lies next to a *vagD* homolog, but its linkage to an IS*1* copy is interrupted by insertion of IS*Ec12*. Figure 6.Genome contexts of plu0597 and plu0598 homologs (shaded boxes) in eubacterial genomes. Repeat sequences are drawn as triangles. The accession numbers of the sources are: (**a**) Refseq NC_010645; (**b**) Refseq NC_010524; (**c**) Refseq NC_010409; (**d**) Genbank AJ851089; (**e**) Refseq NC_006816; (**f**) Refseq NC_009837.

DISCUSSION
==========

We have identified a novel putative mobile genetic element that is flanked by direct repeats using genome comparison and genome context analysis. This element encodes a DNA methyltransferase, a restriction nuclease lacking detectable sequence similarity to any characterized protein and showing only remote secondary structure similarity to PD-(D/E)XK enzymes, and two other genes of unknown functions. The restriction enzyme, designated R.PluTI, specifically cleaved the sequence 5′-GGCGC↓C-3′. Kinetic analysis and gel filtration suggested it is a tetrameric Type IIF enzyme. The DNA methyltransferase M.PluTI modified DNA to protect it from cleavage by R.PluTI. Thus, R.PluTI and M.PluTI form an RM system. In light of all the evidence, this unit likely represents a mobile element composed of an RM system with the plu0597/plu0598 gene pair that is integrated into the genome.

Reaction mechanism of R.PluTI
-----------------------------

R.PluTI showed cleavage preference for a two-site SC substrate over one-site SC substrates. It cleaved both sites in a two-site SC substrate in a concerted manner ([Figure 3](#F3){ref-type="fig"}d), which indicates that this is a Type IIF enzyme ([@B13]). R.PluTI cleaved only one bond in the one-site SC plasmid, liberating OC product at a higher rate than completely cleaved FLL product ([Figure 3](#F3){ref-type="fig"}b). These kinetics are similar to those of NgoMIV, a Type IIF restriction enzyme ([@B19]). Moreover, addition of an oligoduplex carrying a recognition site to the reaction revealed some interesting features. Similar to other Type IIF enzymes ([@B39]), the oligoduplex enhanced cleavage of a one-site SC plasmid by R.PluTI ([Figure 4](#F4){ref-type="fig"}a), but in the initial phase of the reaction, generation of OC unexpectedly superceded the linear form. This suggested that reactions *in trans*, even in the absence of any apparent steric hindrance, are not as efficient as reactions *in cis* that cleaved all the four bonds. This observation indicated that the reactions *in cis*, along with superhelicity, may provide something more than just close bridging of two sites.

The order of the *V*~max~ values obtained, two-site SC \> two-site linear = one-site linear \> \> one-site SC ([Table 2](#T2){ref-type="table"}), supported a role for superhelicity and *cis--trans* effects in reactions catalyzed by this Type IIF enzyme. Superhelicity appeared to facilitate reaction at two sites *in cis*, but suppress reaction at two sites *in trans*.

Life cycle of the mobile element
--------------------------------

Our genome comparison ([Table 1](#T1){ref-type="table"}) and genome context analysis ([Figure 6](#F6){ref-type="fig"}) strongly suggested that the unit we describe represents a mobile element. The unit may have integrated into the genome by conservative site-specific recombination similar to bacteriophage integration or transposition. In the latter case, this unit may have integrated into the genome as a composite transposon composed of four genes in between two IS*982* copies. The ISs appear from the sequence to be nonfunctional.

What might be the role of the neighboring two genes, plu0597 and plu0598? The proteins of plu0597 family have similarity to helicases, while the plu0598 family proteins have similarity to OLD family nucleases. The plu0597/plu0598 pair might encode a helicase/nuclease pair similar to what is found in the McrBC Type IV restriction system. An alternative, but not mutually exclusive, model is that plu0597 and plu0598 form a novel type of toxin--antitoxin systems that stabilizes the unit. The genome context of gene plu0598, and the similarity of its product to nucleases, together with the conservation of tight linkage of plu0597 and plu0598 and the frequent association with a mobile element ([Figure 6](#F6){ref-type="fig"}), are compatible with the hypothesis that this gene pair represents a typical toxin--antitoxin system composed of a gene for an RNase toxin tightly linked with an antitoxin gene ([@B53]). Nonetheless, we cannot eliminate the possibility that plu0597/plu0598 might encode a recombinase involved in integrating the unit. The nuclease domain detected in plu0598 is associated with both DNase and RNase activities, so we cannot distinguish between these possibilities. Further experimental characterization is required to test these hypotheses.

No other genome sequences are available for other *P. luminescence* strain at present. In the future, comparison with more closely related genomes might reveal an empty site and provide more information about the evolutionary history of the PluTI RM system and the life cycle of the putative mobile element.

Further experiments are necessary to determine if this element can integrate into a genome by the action of the encoded proteins. We do not yet know whether the PluTI RM system is just a passenger in this vehicle or actively participates in its mobility and other phases of the life cycle of this element.

Search for novel structures in DNA-interacting proteins and novel mobile elements
---------------------------------------------------------------------------------

This work employed a systematic genome analysis to detect variable subgenomic units that might contain restriction enzyme genes. Variable units carrying a DNA methyltransferase gene homolog were selected by genome comparison and genome context analysis and neighbor genes screened for the restriction activity after *in vitro* expression. This method depended on the sequence similarity among the DNA methyltransferases rather than among the restriction endonucleases, so it was expected to be capable of detecting restriction enzymes not homologous to previously characterized enzymes, and possibly with a novel structure. The precedent of this procedure discovered a novel fold using pair-wise genome comparison ([@B22; @B23; @B24]). This approach should also allow discovery of many more novel mobile elements, which may or may not contain restriction enzymes, using the rapidly expanding availability of genome sequence information. The details of the bioinformatics procedure will be published elsewhere (M.K., J.M.B., K.H.K. and I.K., unpublished data).

R.PluTI is the first enzyme with the cleavage site 5′-GGCGC↓C-3′ for which amino acid sequence information is publicly available. Sequence is also available for two neoschizomers, R.KasI (5′-G↓GCGCC-3′) and R.SfoI (5′-GGC↓GCC-3′), opening the possibility for future detailed analysis of sequence--structure--function relationships ([@B20]).

The R.PluTI family includes the protein Maqu_1714 from *Marinobacter aquaeolei* VT8, which is shorter than other members. Its sequence corresponds to the C-terminal part of other family members (residues 147--322 of R.PluTI). Incidentally, the secondary structure of this region bears remote resemblance to the pattern characteristic of the PD-(D/E)XK fold ([@B54]), namely.α1 − β2 − β3 − β4 − α2 − β5..., with β3 preceded by a conserved dipeptide 210-GD-211 and a semi-conserved motif 220-HX(T/S)-222 (numbering for R.PluTI) in positions corresponding to the PD and (D/E)XK half-motifs. While the D residue is almost invariant among PD-(D/E)XK enzymes, charged residues from the (D/E)XK motif are not, and can be substituted with many other residues (e.g. FTH in the Vsr nuclease), or 'migrate' to non-homologous positions in the sequence ([@B55]). However, while 'sequence gazing' might prompt us to speculate that R.PluTI might contain a C-terminal PD-(D/E)XK domain, possibly with a new type of active site, at this point, none of the state-of-the-art bioinformatics methods applied provided statistically significant support for this prediction. Thus, R.PluTI may be unrelated to PD-(D/E)XK nucleases and may exhibit a different novel fold.
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[^1]: ^a^Annotations not available.

[^2]: ^b^Top hit by BLASTX.

[^3]: See [Supplementary Figure S6](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1) for the substrates and [Supplementary Figure S5](http://nar.oxfordjournals.org/cgi/content/full/gkp1221/DC1) for the measurements.
